Home > Compound List > Compound details
50-65-7 molecular structure
click picture or here to close

5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide

ChemBase ID: 4480
Molecular Formular: C13H8Cl2N2O4
Molecular Mass: 327.11962
Monoisotopic Mass: 325.98611211
SMILES and InChIs

SMILES:
c1cc(c(cc1[N+](=O)[O-])Cl)NC(=O)c1c(ccc(c1)Cl)O
Canonical SMILES:
Clc1ccc(c(c1)C(=O)Nc1ccc(cc1Cl)[N+](=O)[O-])O
InChI:
InChI=1S/C13H8Cl2N2O4/c14-7-1-4-12(18)9(5-7)13(19)16-11-3-2-8(17(20)21)6-10(11)15/h1-6,18H,(H,16,19)
InChIKey:
RJMUSRYZPJIFPJ-UHFFFAOYSA-N

Cite this record

CBID:4480 http://www.chembase.cn/molecule-4480.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide
IUPAC Traditional name
niclosamide
Brand Name
Niclocide
Synonyms
5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide
Niclosamide
2′,5-Dichloro-4′-nitrosalicylanilide
Niclosamide
2',5-Dichloro-4-nitrosalicylanilide
Niclosamide (Niclocide)
2′,5-二氯-4′-硝基水杨酸酰替苯胺
氯硝柳胺
CAS Number
50-65-7
EC Number
200-056-8
MDL Number
MFCD00057597
Beilstein Number
2820605
PubChem SID
160967912
24278585
99443295
PubChem CID
4477
ATC CODE
QP52AG03
P02DA01
CHEMBL
1448
Chemspider ID
4322
DrugBank ID
DB06803
KEGG ID
D00436
Unique Ingredient Identifier
8KK8CQ2K8G
Wikipedia Title
Niclosamide

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem ALOGPS 2.1
Acid pKa 6.8910413  H Acceptors
H Donor LogD (pH = 5.5) 3.8924754 
LogD (pH = 7.4) 3.2942405  Log P 3.909639 
Molar Refractivity 79.5025 cm3 Polarizability 29.329649 Å3
Polar Surface Area 92.47 Å2 Rotatable Bonds
Lipinski's Rule of Five true 
Log P 4.49  LOG S -4.61 
Solubility (Water) 7.99e-03 g/l 

PROPERTIES

PROPERTIES

Physical Property Safety Information Pharmacology Properties Product Information Bioassay(PubChem)
Melting Point
225-230 °C expand Show data source
Vapor Pressure
Very low at room temp expand Show data source
Hydrophobicity(logP)
4.345 expand Show data source
Storage Condition
Room Temperature (15-30°C) expand Show data source
RTECS
VN8400000 expand Show data source
UN Number
3077 expand Show data source
MSDS Link
Download expand Show data source
Download expand Show data source
German water hazard class
2 expand Show data source
Hazard Class
9 expand Show data source
Packing Group
3 expand Show data source
GHS Pictograms
GHS09 expand Show data source
GHS Signal Word
Warning expand Show data source
GHS Hazard statements
H400 expand Show data source
GHS Precautionary statements
P273 expand Show data source
Personal Protective Equipment
Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter expand Show data source
RID/ADR
UN 3077 9/PG 3 expand Show data source
Target
STAT expand Show data source
Purity
95% expand Show data source
Salt Data
Free Base expand Show data source
Certificate of Analysis
Download expand Show data source
Empirical Formula (Hill Notation)
C13H8Cl2N2O4 expand Show data source

DETAILS

DETAILS

MP Biomedicals MP Biomedicals DrugBank DrugBank Wikipedia Wikipedia Sigma Aldrich Sigma Aldrich
MP Biomedicals - 02155827 external link
(2',5-Dichloro-4-nitrosalicylanilide)
DrugBank - DB06803 external link
Item Information
Drug Groups approved
Description Niclosamide is used for the treatment of most tapeworm infections. Helminths (worms) are multicellular organisms that infect very large numbers of humans and cause a broad range of diseases. Over 1 billion people are infected with intestinal nematodes, and many millions are infected with filarial nematodes, flukes, and tapeworms. They are an even greater problem in domestic animals.

Indication For the treatment of tapeworm and intestinal fluke infections: Taenia saginata (Beef Tapeworm), Taenia solium (Pork Tapeworm), Diphyllobothrium latum (Fish Tapeworm), Fasciolopsis buski (large intestinal fluke). Niclosamide is also used as a molluscicide in the control of schistosomiasis.
Pharmacology Niclosamide is an antihelminth used against tapeworm infections. It may act by the uncoupling of the electron transport chain to ATP synthase. The disturbance of this crucial metabolic pathway prevents creation of adenosine tri-phosphate (ATP), an essential molecule that supplies energy for metabolism.
Toxicity Infrequent, mild, and transitory adverse events include nausea, vomiting, diarrhea, and abdominal discomfort.
Affected Organisms
Helminthic Microorganisms
Absorption Niclosamide appears to be minimally absorbed from the gastrointestinal tract—neither the drug nor its metabolites have been recovered from the blood or urine.
References
Rosenthal Philip J, "Chapter 53. Clinical Pharmacology of the Antihelminthic Drugs" (Chapter). Katzung BG: Basic & Clinical Pharmacology, 11e: "http://www.accessmedicine.com/content.aspx?aID=4516635":http://www.accessmedicine.com/content.aspx?aID=4516635.
2010. Detailed Drug Information for the Consumer?. Greenwood Village, CO. Thomson Reuters. ISBN-10: 1-56363-575-5. ISSN: 0740-4174. STAT!Ref Online Electronic Medical Library.
External Links
Wikipedia
Drugs.com
Sigma Aldrich - N3510 external link
Application
Niclosamide is a teniacide in the anthelmintic family. It is effective against cestodes that infect humans. Niclosamide is used to study the Wnt/Frizzled-1 signaling pathway. It is used to inhibit the transcription and DNA binding of NF-κB in AML cells and ito induce apoptosis1.
Biochem/physiol Actions
Niclosamide is used to study the Wnt/Frizzled-1 signaling pathway. It inhibits mitochondrial oxidative phosphorylation of parasitic helminths.
Niclosamide uncouples oxidative phosphorylation in the tapeworm. It inhibits mitochondrial oxidative phosphorylation of parasitic helminths. It inhibits the NF-κB pathway in acute myelogenous leukemia (AML) cells. Niclosamide inhibits the transcription and DNA binding of NF-κB. It blocks tumor necrosis factor-induced IκBα phosphorylation, translocation of p65, and expression of NF-κB- regulated genes in AML cells. It increases ROS levels to induce apoptosis in AML cells1.

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • • 2010. Detailed Drug Information for the Consumer?. Greenwood Village, CO. Thomson Reuters. ISBN-10: 1-56363-575-5. ISSN: 0740-4174. STAT!Ref Online Electronic Medical Library.
  • • Rosenthal Philip J, "Chapter 53. Clinical Pharmacology of the Antihelminthic Drugs" (Chapter). Katzung BG: Basic & Clinical Pharmacology, 11e: "http://www.accessmedicine.com/content.aspx?aID=4516635":http://www.accessmedicine.com/content.aspx?aID=4516635.
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle